Howard L Weiner, MD

Affiliations: 
1985- Neurology Harvard Medical School - Brigham and Women's Hospital 
Area:
Multiple Sclerosis
Website:
http://weinerlab.bwh.harvard.edu/?page_id=154
Google:
"Howard Weiner"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zurawski J, Tauhid S, Chu R, et al. (2019) 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519885106
Palotai M, Nazeri A, Cavallari M, et al. (2019) History of fatigue in multiple sclerosis is associated with grey matter atrophy. Scientific Reports. 9: 14781
Rezende RM, Nakagaki BN, Moreira TG, et al. (2019) γδ T Cell-Secreted XCL1 Mediates Anti-CD3-Induced Oral Tolerance. Journal of Immunology (Baltimore, Md. : 1950)
Garo LP, Ajay AK, Fujiwara M, et al. (2019) Smad7 Controls Immunoregulatory PDL2/1-PD1 Signaling in Intestinal Inflammation and Autoimmunity. Cell Reports. 28: 3353-3366.e5
Singhal T, O'Connor K, Dubey S, et al. (2019) Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study. Neurology(R) Neuroimmunology & Neuroinflammation. 6
Rezende RM, Lopes ME, Menezes GB, et al. (2019) Visualizing Lymph Node Structure and Cellular Localization using Ex-Vivo Confocal Microscopy. Journal of Visualized Experiments : Jove
Palotai M, Cavallari M, Koubiyr I, et al. (2019) Microstructural fronto-striatal and temporo-insular alterations are associated with fatigue in patients with multiple sclerosis independent of white matter lesion load and depression. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519869185
Yano H, Gonzalez C, Healy BC, et al. (2019) Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes. Multiple Sclerosis and Related Disorders. 35: 119-127
Singhal T, O'Connor K, Dubey S, et al. (2019) Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study. Neurology(R) Neuroimmunology & Neuroinflammation. 6: e587
Peroni S, Sorosina M, Malhotra S, et al. (2019) A pharmacogenetic study implicates in the response to Interferon-β in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519851428
See more...